Examkin

Question

Difficulty: HardPharmacologic Interventions

Paramedics bring a 45-year-old female to the emergency department due to worsening dyspnea, blurred vision, and an intense headache over the past 12 hours. The patient was diagnosed with diffuse cutaneous systemic sclerosis four years ago and takes mycophenolate mofetil. Vital signs show a temperature of 37.1°C (98.8°F), blood pressure of 228/118 mm Hg, pulse of 106/min, and respiratory rate of 24/min. Pulse oximetry is 94% on room air. Physical examination is notable for diffuse skin thickening sparing the clavicles and bilateral basilar crackles.

Laboratory studies reveal:
Hemoglobin: 8.9 g/dL
Platelets: 78,000/mm³
Creatinine: 3.6 mg/dL (baseline: 0.8 mg/dL)
Lactate dehydrogenase: 940 U/L
Urinalysis: 2+ protein, no red blood cell casts

A peripheral blood smear demonstrates fragmented red blood cells. Which of the following is the most appropriate initial pharmacologic intervention?

  1. Oral captoprilAnswer
  2. B
    Intravenous labetalol
  3. C
    Intravenous sodium nitroprusside
  4. D
    Intravenous methylprednisolone
  5. E
    Intravenous eculizumab

Answer

Oral captopril
The correct answer is oral captopril. This patient is presenting with scleroderma renal crisis (SRC), characterized by malignant hypertension, acute kidney injury, and microangiopathic hemolytic anemia (evidenced by schistocytes, thrombocytopenia, and elevated LDH) in the setting of systemic sclerosis. The pathophysiology involves intimal proliferation of the renal arcuate and interlobular arteries, leading to severe renal ischemia and massive activation of the renin-angiotensin-aldosterone system (RAAS). ACE inhibitors are the cornerstone of treatment and should be initiated immediately to reverse the RAAS activation. Captopril is the preferred agent because its short half-life allows for rapid and safe dose titration. Unlike most cases of acute kidney injury, where ACE inhibitors are typically withheld or discontinued, SRC uniquely requires their immediate administration to preserve long-term renal function and reduce mortality.

Step-by-Step Solution

1
Identify the primary clinical syndrome from the presentation.
The patient has Scleroderma Renal Crisis (SRC), defined by malignant hypertension, acute kidney injury, and microangiopathic hemolytic anemia in a patient with systemic sclerosis.
Synthesizing the underlying rheumatologic diagnosis with the acute hypertensive and hematologic findings is required to identify the specific crisis.
2
Determine the underlying pathophysiology driving the crisis.
SRC is driven by intense renal vascular ischemia leading to massive activation of the renin-angiotensin-aldosterone system (RAAS).
Understanding the RAAS-driven mechanism distinguishes SRC from other generic hypertensive emergencies.
3
Select the appropriate targeted pharmacologic intervention.
A short-acting ACE inhibitor, such as oral captopril, must be initiated immediately.
ACE inhibitors are uniquely indicated in SRC to break the cycle of renin release, and they are mandatory even when acute kidney injury is present.

Key Concept

Scleroderma Renal Crisis presents with severe hypertension, acute kidney injury, and microangiopathic hemolytic anemia. It must be treated immediately with short-acting ACE inhibitors (e.g., captopril), overriding the usual contraindication of using ACE inhibitors in acute kidney injury.
Estimated Time:1m 30s
Rate this question

Topics

Pharmacologic Interventions

More questions from this topic